Stroke-prone spontaneously hypertensive rats (SHRSP) are at increased risk of cerebral infarction. In SHRSP, but not in the normotensive reference strain (WKY), a large infarct occurs after occlusion of a major cerebral artery. The infarct location within the territory normally supplied by the occluded vessel suggests inadequate collateral circulation. We hypothesize that deficient vasodilation of the anastomosis (midzone collateral) predisposes SHRSP to infarction. Long- term objectives are to characterize the pathophysiology of the cerebral collateral circulation in SHRSP and to investigate mechanisms to improve this flow.
The specific aims are to 1) assess pial artery blood pressure and vascular conductance to determine if the deficient vasodilation is located primarily within cortex or in small (less than 75mu/m, i.d.) pial surface anastomoses, 2) identify possible cellular regulatory mechanisms (nitric oxide synthase, cholinergic, serotonergic) responsible for inadequate vasodilation or reduced collateral blood flow through small anastomoses, 3) determine the mechanism by which chronic unilateral common carotid occlusion protects SHRSP against a large ipsilateral infarct after middle cerebral artery occlusion, 4) identify the abnormality in a large (greater than 150 mu/m, id.d) anastomosis and characterize the effect of increased hemodynamic load (flow conditioning) on the abnormality and development of the anastomosis, and 5) determine if the dilator deficiency in SHRSP is also present in a selectively bred normotensive cognitive strain having the stroke characteristic and in the hypertensive protected congenic strain. Accomplishments of the objectives is expected to provide better insight needed for making interventions to alter vascular pathophysiologic mechanisms of hypertension that predispose to stroke.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL018575-21
Application #
5213204
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
1996
Total Cost
Indirect Cost
Rocchini, Albert P; Yang, John Q; Smith, Marla J et al. (2010) Serial changes in norepinephrine kinetics associated with feeding dogs a high-fat diet. J Clin Hypertens (Greenwich) 12:117-24
Kamal, Mohamed A; Keep, Richard F; Smith, David E (2008) Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity. Drug Metab Pharmacokinet 23:236-42
Duan, Sheng Zhong; Ivashchenko, Christine Y; Whitesall, Steven E et al. (2007) Direct monitoring pressure overload predicts cardiac hypertrophy in mice. Physiol Meas 28:1329-39
Hu, Yongjun; Shen, Hong; Keep, Richard F et al. (2007) Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J Neurochem 103:2058-65
Ennis, Steven R; Keep, Richard F (2007) Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab 27:1573-82
Shen, Hong; Ocheltree, Scott M; Hu, Yongjun et al. (2007) Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos 35:1209-16
Xiang, Jianming; Chiang, Pei-Pei; Hu, Yongjun et al. (2006) Role of PEPT2 in glycylsarcosine transport in astrocyte and glioma cultures. Neurosci Lett 396:225-9
Ennis, S R; Keep, R F (2006) Effects of 2,4-dinitrophenol on ischemia-induced blood-brain barrier disruption. Acta Neurochir Suppl 96:295-8
Carello, Katari A; Whitesall, Steven E; Lloyd, Mary C et al. (2006) Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. Am J Physiol Heart Circ Physiol 290:H209-16
Xiang, Jianming; Hu, Yongjun; Smith, David E et al. (2006) PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes. Brain Res 1122:18-23

Showing the most recent 10 out of 291 publications